Literature DB >> 23443336

Major vascular involvement in Behçet's disease: a retrospective study of 796 patients.

Yunyun Fei1, Xuemei Li, Sen Lin, Xiaojun Song, Qingjun Wu, Yanlin Zhu, Xin Gao, Wen Zhang, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang.   

Abstract

Behçet's disease (BD) is a multi-systemic inflammatory disorder which can affect all types and sizes of blood vessels. This study aims to evaluate the prevalence and characteristics of vascular involvement in BD. Among 796 patients diagnosed with BD, 102 patients (81 male, 21 female) with vascular involvement were included, whose detailed clinical characteristics were recorded. The diagnosis of vascular lesions was made on clinical signs, by Doppler ultrasonography, and/or angiography using computed tomographic or magnetic resonance techniques. Vascular involvement occurred in 12.8 % of BD patients. Male to female ratio was 3.86:1. Mean age at onset of vascular involvement was 29.5 ± 11.3 years. Vascular lesion was the initial sign of BD in 28 patients, accounting for 27.5 %. Of 102 BD patients with vascular involvement, 72 had venous lesions (70.6 %) and 56 had arterial lesions (54.9 %), among which 26 (25.5 %) patients had both venous and arterial involvements. Female BD patients were more often involved with arterial lesions, whereas male BD patients developed venous lesions more often than females, P = 0.000. The most common type of vascular involvement was deep venous thrombosis in lower extremities (n = 49), other affected venous sites including inferior vena cava, superior vena cava, and cerebral venous. The prominent type of arterial lesions was dilatation (n = 25, including 24 cases of aneurysms); other types included eight cases of occlusion and 23 cases of stenosis. The main locations of arterial lesions were the aorta (n = 19), lower extremity arteries (n = 15), pulmonary arteries (n = 13), coronary arteries (n = 5), and subclavian arteries (n = 5). Compared with those without vascular lesions, ocular involvement, genital ulcers, and arthritis were significantly less frequent among patients with vasculo-BD (23.5 vs 35.2 %, P = 0.024; 54.9 vs 76.5 %, P = 0.000; 19.6 vs 30.5 %, P = 0.026), whereas a higher frequency of cardiac involvement was found in vasculo-BD patients (20.6 vs 3.6 %, P = 0.000). Vascular involvement is a complication in BD patients. This study illustrated that venous lesions are more frequently involved than arterial lesions. Vascular lesions correlated with a high frequency of cardiac involvement and a low incidence of ocular lesions, genital ulcers, and arthritis.

Entities:  

Mesh:

Year:  2013        PMID: 23443336     DOI: 10.1007/s10067-013-2205-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

Review 1.  Pulmonary manifestations of Behçet's disease.

Authors:  F Erkan; A Gül; E Tasali
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

2.  Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases.

Authors:  Rifkiye Sarica-Kucukoglu; Afet Akdag-Kose; Murat KayabalI; Kurtulus Didem Yazganoglu; Rian Disci; Dilek Erzengin; Gulsevim Azizlerli
Journal:  Int J Dermatol       Date:  2006-08       Impact factor: 2.736

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Behcet's disease in Iran: analysis of 6500 cases.

Authors:  Fereydoun Davatchi; Farhad Shahram; Cheyda Chams-Davatchi; Hormoz Shams; Abdolhadi Nadji; Massoomeh Akhlaghi; Tahereh Faezi; Zahra Ghodsi; Roghieh Larimi; Farima Ashofteh; Bahar Sadeghi Abdollahi
Journal:  Int J Rheum Dis       Date:  2010-10       Impact factor: 2.454

Review 5.  Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature.

Authors:  Guillaume Geri; Bertrand Wechsler; Du Le Thi Huong; Richard Isnard; Jean-Charles Piette; Zahir Amoura; Mathieu Resche-Rigon; Patrice Cacoub; David Saadoun
Journal:  Medicine (Baltimore)       Date:  2012-01       Impact factor: 1.889

6.  [Behçet's disease in Tunisia. Clinical study of 519 cases].

Authors:  S B'chir Hamzaoui; A Harmel; K Bouslama; M Abdallah; M Ennafaa; S M'rad; M Ben Dridi
Journal:  Rev Med Interne       Date:  2006-08-18       Impact factor: 0.728

7.  Behçet's disease in Saudi Arabia.

Authors:  A N al-Dalaan; S R al Balaa; K el Ramahi; Z al-Kawi; S Bohlega; S Bahabri; M A al Janadi
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

8.  Characteristics of vascular involvement in Behçet's disease.

Authors:  N Düzgün; A Ateş; O T Aydintuğ; O Demir; U Olmez
Journal:  Scand J Rheumatol       Date:  2006 Jan-Feb       Impact factor: 3.641

Review 9.  Pulmonary manifestations in Behçet's syndrome.

Authors:  I Raz; E Okon; T Chajek-Shaul
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

Review 10.  Major arterial involvement and review of Behcet's disease.

Authors:  Ufuk Alpagut; Murat Ugurlucan; Enver Dayioglu
Journal:  Ann Vasc Surg       Date:  2007-03       Impact factor: 1.466

View more
  33 in total

Review 1.  Aortic involvement in relapsing polychondritis: case-based review.

Authors:  Mustafa Erdogan; Sinem Nihal Esatoglu; Gulen Hatemi; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2019-11-25       Impact factor: 2.631

2.  Anterior mediastinal fat in Behçet's disease: qualitative and quantitative CT analysis.

Authors:  Sang Yub Lee; Jongmin Lee; Hui Joong Lee; Sun Ju Choi; Myong Hun Hahm; Sung Won Yoon
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-10       Impact factor: 2.357

3.  Vasculo-Behçet disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET/CT).

Authors:  Makiko Yashiro Furuya; Jumpei Temmoku; Yuya Fujita; Naoki Matsuoka; Tomoyuki Asano; Shuzo Sato; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2019-07-20

4.  Pattern of pulmonary vasculitis and major vascular involvement in Hughes-Stovin syndrome (HSS): brief report of eight cases.

Authors:  Yasser Emad; Yasser Ragab; Ossama Ibrahim; Ahmed Saad; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2019-12-18       Impact factor: 2.980

5.  Peripheral pulmonary artery stenosis as a cause of pulmonary hypertension in adults.

Authors:  Adriano R Tonelli; Mostafa Ahmed; Fadi Hamed; Lourdes R Prieto
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

6.  Abdominal aortic aneurysm causing lumbar vertebral erosion in Behçet's disease presenting by low back pain.

Authors:  Merve Örücü; Duygu Keleş; Elif Peker; Mehmet Çakıcı; Naota Shimbori; İlhan Erden; Levent Yazıcıoğlu; Birkan Sonel Tur
Journal:  Rheumatol Int       Date:  2014-06-25       Impact factor: 2.631

7.  Intracardiac thrombosis in Behçet's Disease successfully treated with immunosuppressive agents: A case of vascular pathergy phenomenon.

Authors:  Francisco Galeano-Valle; Pablo Demelo-Rodriguez; Luís Álvarez-Sala-Walther; Blanca Pinilla-Llorente; Miguel Jesús Echenagusia-Boyra; Hugo Rodriguez-Abella; Jorge Del-Toro-Cervera
Journal:  Intractable Rare Dis Res       Date:  2018-02

Review 8.  Autoinflammatory Disease-Associated Vasculitis/Vasculopathy.

Authors:  Mansour Alghamdi
Journal:  Curr Rheumatol Rep       Date:  2018-11-17       Impact factor: 4.592

9.  Urgent Surgical Management of Deep Femoral Artery Aneurysm in a Patient with Pre-Vasculo-Behcet Status.

Authors:  Tetsuya Sato; Harunobu Matsumoto; Naoyuki Kimura; Homore Okamura; Koichi Adachi; Koichi Yuri; Atsushi Yamaguchi; Shigeki Yamada; Hideo Adachi
Journal:  Ann Vasc Dis       Date:  2015-05-26

10.  Genital aphthosis in Behçet's disease: is it associated with less eye involvement?

Authors:  Seyedeh Tahereh Faezi; Cheyda Chams-Davatchi; S Zahra Ghodsi; Farhad Shahram; Abdolhadi Nadji; Massoomeh Akhlaghi; Kamran Moradi; Pedram Paragomi; Golnaz Ghazizadeh Esslami; Bahar Sadeghi Abdollahi; Farimah Ashofteh; Fereydoun Davatchi
Journal:  Rheumatol Int       Date:  2014-04-12       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.